The Nordic Group Acquires Rights to Trasylol® From Bayer HealthCare
Hoofddorp, Netherlands (ots/PRNewswire) - Nordic Group announced today that it has reached an agreement with Bayer HealthCare in which Nordic will acquire Trasylol(R) (aprotinin injection) worldwide excluding the United States. Under this agreement, Nordic will become the Marketing Authorization Holder for aprotinin in the relevant Territories. This follows the opinion ...
mehr